RecruitingNot Applicable

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

Germany200 participantsStarted 2021-07-21

Plain-language summary

Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient is minimum 18 years old * Informed Consent in the documentation of clinical and radiological results * Patient has indication according to Instructions for Use (IFU) * Patient is not pregnant Exclusion Criteria: * Patient's clear unability or unwillingness to participate in follow-up examinations

What they're measuring

Change of Pain

Timeframe: preoperatively, at 3 months postoperatively and at 12 months postoperatively

Trial details

NCT IDNCT05296889

SponsorAesculap AG

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-06

Contact for this trial

Sarah Mattes

+497461950 sarah.mattes@aesculap.de

View on ClinicalTrials.gov More Spine Fracture trials